4 days Does BioMarin (BMRN) Have the Potential to Rally 40.54% as Wall Street Analysts Expect? Zacks

The average of price targets set by Wall Street analysts indicates a potential upside of 40.5% in BioMarin (BMRN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Biomarin Pharma (BMRN) · Wall Street